| Filed On | Filing |
|---|---|
| 26 Oct 2026 |
Form 4: Perriman Damien Alan, Chief Commercial Officer
Received 3,922 shares by exercise or conversion · Sold 3,729 shares ($19.4K) |
| 21 Oct 2026 |
Form 4/A: Korman Tyler Paz, Chief Scientific Officer
Holds 729,123 shares of Common Stock |
| 19 Oct 2026 |
Form 4: Rayo Edgardo Javier, Director
Granted 25,000 Stock Option (right to buy) |
| 19 Oct 2026 |
Form 4: Marlett Christopher A, Director
Granted 10,000 Stock Option (right to buy) |
| 19 Oct 2026 |
Form 4: Lalonde James Joseph, Director
Granted 10,000 Stock Option (right to buy) |
| 19 Oct 2026 |
Form 4: Digiandomenico Anthony, Director
Granted 10,000 Stock Option (right to buy) |
| 19 Oct 2026 |
Form 4: Bowie James Ulrich, Director
Granted 10,000 Stock Option (right to buy) |
| 19 Oct 2026 |
Form 4: Bell Lon E, Director
Granted 10,000 Stock Option (right to buy) |
| 09 Oct 2026 |
8-K: Other Events
Attached is an Investor Presentation of eXoZymes Inc., a Nevada corporation, dated as of October 6, 2026, that may be provided to investment bankers and other offering participants and current and potential investors in securities of the... |
| 28 Sep 2026 | DEFA14A |
| 28 Sep 2026 | Proxy statement: annual meeting on November 13, 2026 |
| 18 Sep 2026 |
8-K: Other Events
The Company determined to hold its 2026 annual meeting on November 13, 2026, and plans to distribute its proxy statement and proxy to the shareholders on or about September 28, 2026. The record date for the meeting was September 15, 2026. |
| 17 Sep 2026 |
Form 4: Nawaz Fouad, Vice President- Finance
Granted 45,000 Stock Option (right to buy) |
| 02 Sep 2026 |
Form 4: Heltzen Michael, Chief Executive Officer
Received 8,841 shares as a grant or award ($56.6K) · Bought 350 shares ($2.63K) · Bought 505 shares ($3.78K) |
| 25 Aug 2026 |
Form 4: Perriman Damien Alan, Chief Commercial Officer
Received 19,612 shares by exercise or conversion |
| 25 Aug 2026 |
Form 4: Korman Tyler Paz, Chief Scientific Officer
Received 32,964 shares by exercise or conversion |
| 13 Aug 2026 | 10-Q |
| 01 Jul 2026 | 8-K: Entry into a Material Definitive Agreement |
| 30 Jun 2026 | 424B5 |
| 26 Jun 2026 | 8-K: Regulation FD Disclosure |
Loading...
